ArticleOncotarget2017

Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients.

Christopher J Greene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.